Sign Up Today and Learn More About Pendulum Therapeutics Stock
Invest in or calculate the value of your shares in Pendulum Therapeutics or other pre-IPO companies through EquityZen's platform.

Pendulum Therapeutics Stock (PENT)
Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.
About Pendulum Therapeutics Stock
Founded
2013
Headquarters
San Francisco, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Pendulum Therapeutics believes therapies developed using evidence-based microbiome science and DNA sequencing can help heal the body from within. Armed with 13 patents and 42 pending, the company introduced its flagship product Pendulum Glucose Control, a medical probiotic, in 2020 and demonstrated its efficacy in lowering blood sugar spikes and reducing A1C in a published clinical trial. Founded in 2013 by a diverse team of scientists with deep microbiology, biochemistry, computational, and clinical expertise, Pendulum has raised $111 million to date from Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, AME Cloud Ventures and Mayo Clinic among others. Pendulum Therapeutics is headquartered in San Francisco.
Pendulum Therapeutics Press Mentions
Stay in the know about the latest news on Pendulum Therapeutics
Methods of producing or providing metabolites of pathways associated with the …
patents • Apr 02, 2025
Methods of treating skin inflammation and related compositions
patents • Apr 02, 2025
Methods and compositions for treatment of microbiome associated disorders
patents • Apr 02, 2025
Methods and Compositions Relating to Microbial Treatment and Diagnosis of …
patents • Feb 12, 2025
Methods and compositions for treating liver disorders
patents • Feb 12, 2025
Pendulum Therapeutics Management
Leadership team at Pendulum Therapeutics
COO
Mohan Iyer
Chief Medical Officer
Adam Perlman

Join now and verify your accreditation status to gain access to:
- Pendulum Therapeutics Current Valuation
- Pendulum Therapeutics Stock Price
- Pendulum Therapeutics Management
- Available deals in Pendulum Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Pendulum Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Pendulum Therapeutics Revenue and Financials
- Pendulum Therapeutics Highlights
- Pendulum Therapeutics Business Model
- Pendulum Therapeutics Risk Factors
- Pendulum Therapeutics Research Report from SACRA Research
Trading Pendulum Therapeutics Stock
How to invest in Pendulum Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Pendulum Therapeutics through EquityZen funds. These investments are made available by existing Pendulum Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Pendulum Therapeutics stock?
Shareholders can sell their Pendulum Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."